Related references
Note: Only part of the references are listed.Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes
Asako Itakura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Activated factor XI and tissue factor in chronic obstructive pulmonary disease: Links with inflammation and thrombin generation
Milosz Jankowski et al.
THROMBOSIS RESEARCH (2011)
Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
Fatima Akdim et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Inhibition of Factor XIa as a New Approach to Anticoagulation
William A. Schumacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Intrinsic Coagulation Activation and the Risk of Arterial Thrombosis in Young Women Results From the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Case-Control Study
B. Siegerink et al.
CIRCULATION (2010)
Antisense Treatment in Human Prostate Cancer and Melanoma
C. Di Cresce et al.
CURRENT CANCER DRUG TARGETS (2010)
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Erik I. Tucker et al.
BLOOD (2009)
Factor XI contributes to thrombin generation in the absence of factor XII
Dmitri V. Kravtsov et al.
BLOOD (2009)
Rivaroxaban in Orthopedic Surgery - A Change of Paradigm?
Sam Schulman
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2009)
Antisense oligonucleotide pharmacokinetics and metabolism
Richard S. Geary
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Prevention of venous thromboembolism in medical patients and outpatients
Gregg J. Stashenko et al.
NATURE REVIEWS CARDIOLOGY (2009)
New anticoagulants - towards the development of an ideal anticoagulant
S. Haas
VASA-JOURNAL OF VASCULAR DISEASES (2009)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis
Erik I. Tucker et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
Rosie Z. Yu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice
X. Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates
A Gruber et al.
BLOOD (2003)
Inherited factor XI deficiency confers no protection against acute myocardial infarction
O Salomon et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Gene targeting in hemostasis. Factor XI
D Gailani
FRONTIERS IN BIOSCIENCE-LANDMARK (2001)
Preparation and analysis of the common urinary forms of human chorionic gonadotropin
S Birken et al.
METHODS (2000)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
